Horizon Infusions

Based in the US, Horizon Infusions operates a prominent network of infusion centers, specializing in providing infusion therapy services with a focus on patient care and comfort. Horizon Infusions, founded in 1997 and headquartered in Blue Ash, US, offers infusion therapy services. The company underwent a significant change in ownership in February 2025 when Rubicon Founders, along with management, acquired a majority stake from InFUSE Holdings, Inc. , and Broadoal Capital for USD 130 mn.

Tim Johnson is the current CEO overseeing operations. The firm has completed a total of 2 deals to date, with the latest deal occurring on February 4, 2025, which involved a Secondary Stock Purchase, raising USD 130 mn. Horizon Infusions primarily provides infusion therapy services, operating as a leading network of infusion centers in Ohio. The company is committed to delivering expert care in a patient-focused environment, with advanced facilities and a highly experienced clinical team.

Their services cater to a diverse clientele, including patients undergoing various infusion therapies such as Xolair and IVIG. The centers are strategically located within a 30-minute drive of 90% of Ohio's population, ensuring broad accessibility, and serve patients covered by Medicaid, Medicare, and private insurance plans. Horizon Infusions generates revenue by providing infusion therapy services directly to patients and through partnerships with healthcare providers. Transactions occur on a per-visit basis, and the company is in-network with all major insurance plans, facilitating access to its services for a wide range of patients.

Revenue is derived from insurance reimbursements for the therapies provided, allowing for strong relationships with patients and referring healthcare providers. In February 2025, Horizon Infusions secured funding of USD 130 mn from Rubicon Founders to expand its portfolio of healthcare services businesses. The company plans to enhance its service offerings and explore opportunities in new market regions, aiming for a broader outreach to meet diverse patient needs.